SynthesisThoracic cancer2020

Efficacy and safety of PD-1/PD-L1 inhibitor plus chemotherapy versus chemotherapy alone as first-line treatment for extensive-stage small cell lung cancer: A systematic review and meta-analysis.

Shuang Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.